Funded by the NIH as part of the second phase of the Knockout Mouse Project (KOMP2), the DTCC Consortium is creating a repository of knockout mouse lines and phenotype data as part of an international effort to help researchers develop better models of human disease. University of California, Davis (UC Davis), Toronto Centre for Phenogenomics (TCP), Children’s Hospital Oakland Research Institute (CHORI) and Charles River have come together to form the DTCC Consortium for this 5-year research effort. In addition to the DTCC Consortium, the other KOMP2 participants include The Jackson Laboratory as well as the collaboration of Baylor College of Medicine, the Wellcome Trust Sanger Institute and the Medical Research Council (MRC) Harwell.
Listen to this podcast to learn more about the DTCC and its mission.